Archimedes Tech SPAC Partners III Co. closed its first full reporting period as a public company with the architecture of a fresh blank-check shell now fully in place and the period's two material events both visible at quarter-end. The registration statement was declared effective on January 22, 2026; the initial public offering of 27.6 million units (including the full 3.6 million-share over-allotment) priced at $10.00 per unit and closed on January 26, 2026, generating $276.0 million of gross proceeds and triggering the immediate deposit of $276.0 million into an interest-bearing trust account, where it earned $1.78 million of interest income over the remaining nine weeks of the quarter. Three months later, on April 28, 2026, founding Chief Executive Officer Long Long resigned and the Board appointed Ben Landen, the company's co-founder, as the new CEO, retaining him as Chief Technology Officer. The most recent 10-Q (period ended March 31, 2026, filed May 14, 2026) is the cleanest possible read on a post-IPO SPAC: $1.574 million of GAAP net income, $0.06 of basic and diluted net income per ordinary share, $1.110 million of cash outside the trust, $277.776 million of trust assets, and a working-capital surplus of $1.213 million. There is no operating business, no revenue, and no business-combination target; the report's only forward content is the disclosure that management has selected artificial intelligence, cloud services, and automotive technology as its initial search verticals and that the Completion Window runs 24 months from the January 26, 2026 closing.
The investment case at $10.18 per ordinary share on August 13, 2026 is a residual-claim read on a $277.78 million trust plus a small working-capital cushion, with a 24-month clock and an empty pipeline. Market capitalization is roughly $359.0 million on 35.262 million ordinary shares outstanding (27.6 million public plus 7.662 million sponsor founder shares, the latter a pro-forma post-1-for-1.0 share-capitalization count of 6.9 million pre-cap founder shares plus 762,000 sponsor private-placement shares). The trust holds 27.6 million redeemable public shares at $10.06 each (the $10.00 principal plus $0.064 of accrued interest, the latter per-share figure derived from $1.776 million of trust interest over the quarter divided by 27.6 million shares), so the public-share trust floor is $10.06 and the public-share redemption right runs against that floor; the sponsor's 7.662 million ordinary shares carry no trust backing and are valued by the market at roughly $10.18 - an unusually tight spread, indicating that the market is ascribing a small option premium to the sponsor stake rather than the typical 20-30% rights discount. The unit (ARCIU) and the warrant (ARCIW) were authorized to separately trade on Nasdaq on March 16, 2026, and the 52-week range from first trading through August 13, 2026 is $9.83 to $10.31, a 4.8% band. The thesis is a pre-deal SPAC at trust parity; the falsification framework runs on the calendar of a definitive merger agreement and the closing of a business combination, not on operating metrics.